z-logo
open-access-imgOpen Access
Atypical clinical presentation of inflammatory marker negative septic arthritis, osteomyelitis, and bacteremia following a single dose of tocilizumab in the treatment of COVID-19: a case report
Author(s) -
José C. Reyes,
Emmanuel Ogele,
William D. Clapp
Publication year - 2022
Publication title -
journal of emergency and critical care medicine
Language(s) - English
Resource type - Journals
ISSN - 2521-3563
DOI - 10.21037/jeccm-21-121
Subject(s) - tocilizumab , medicine , septic arthritis , bacteremia , osteomyelitis , covid-19 , presentation (obstetrics) , arthritis , immunology , rheumatoid arthritis , surgery , antibiotics , microbiology and biotechnology , disease , infectious disease (medical specialty) , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom